Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes
- PMID: 26265482
- DOI: 10.1177/0969141315595254
Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes
Abstract
Objectives: To clarify the relationship between facility-level mammography interpretive volume and breast cancer screening outcomes.
Methods: We calculated annual mammography interpretive volumes from 2000-2009 for 116 facilities participating in the U.S. Breast Cancer Surveillance Consortium (BCSC). Radiology, pathology, cancer registry, and women's self-report information were used to determine the indication for each exam, cancer characteristics, and patient characteristics. We examined the effect of annual total volume and percentage of mammograms that were screening on cancer detection rates using multinomial logistic regression adjusting for age, race/ethnicity, time since last mammogram, and BCSC registries. "Good prognosis" tumours were defined as screen-detected invasive cancers that were <15 mm, early stage, and lymph node negative at diagnosis.
Results: From 3,098,481 screening mammograms, 9,899 cancers were screen-detected within one year of the exam. Approximately 80% of facilities had annual total interpretive volumes of >2,000 mammograms, and 42% had >5,000. Higher total volume facilities were significantly more likely to diagnose invasive tumours with good prognoses (odds ratio [OR] 1.32; 95% confidence interval [CI] 1.10-1.60, for total volume of 5,000-10,000/year v. 1,000-2,000/year; p-for-trend <0.001). A concomitant decrease in tumours with poor prognosis was seen (OR 0.78; 95%CI 0.63-0.98 for total volume of 5,000-10,000/year v. 1,000-2,000/year).
Conclusions: Mammography facilities with higher total interpretive volumes detected more good prognosis invasive tumours and fewer poor prognosis invasive tumours, suggesting that women attending these facilities may be more likely to benefit from screening.
Keywords: Cancer detection; breast cancer screening; mammography; volume.
© The Author(s) 2015.
Similar articles
-
Biennial versus annual mammography and the risk of late-stage breast cancer.J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9. doi: 10.1093/jnci/djh337. J Natl Cancer Inst. 2004. PMID: 15601639
-
Detection of ductal carcinoma in situ in women undergoing screening mammography.J Natl Cancer Inst. 2002 Oct 16;94(20):1546-54. doi: 10.1093/jnci/94.20.1546. J Natl Cancer Inst. 2002. PMID: 12381707
-
Influence of annual interpretive volume on screening mammography performance in the United States.Radiology. 2011 Apr;259(1):72-84. doi: 10.1148/radiol.10101698. Epub 2011 Feb 22. Radiology. 2011. PMID: 21343539 Free PMC article.
-
Interval breast cancers are not biologically distinct--just more difficult to diagnose.Am J Surg. 1994 Dec;168(6):538-42. doi: 10.1016/s0002-9610(05)80118-7. Am J Surg. 1994. PMID: 7977992 Review.
-
Correcting a decade of negative news about mammography.Clin Imaging. 2020 Apr;60(2):265-270. doi: 10.1016/j.clinimag.2019.03.011. Epub 2019 Apr 4. Clin Imaging. 2020. PMID: 30982701 Review.
Cited by
-
Diagnostic and Practical Value of Abbreviated Contrast Enhanced Magnetic Resonance Imaging in Breast Cancer Diagnostics.Cancers (Basel). 2022 Nov 17;14(22):5645. doi: 10.3390/cancers14225645. Cancers (Basel). 2022. PMID: 36428738 Free PMC article.
-
Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.Breast Cancer Res Treat. 2021 May;187(1):255-266. doi: 10.1007/s10549-020-06057-8. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392846
-
Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection.PeerJ. 2020 Dec 16;8:e10494. doi: 10.7717/peerj.10494. eCollection 2020. PeerJ. 2020. PMID: 33362968 Free PMC article.
-
Multispectral photoacoustic imaging of breast cancer tissue with histopathology validation.Biomed Opt Express. 2025 Feb 12;16(3):995-1005. doi: 10.1364/BOE.547262. eCollection 2025 Mar 1. Biomed Opt Express. 2025. PMID: 40109539 Free PMC article.
-
Fabrication of a Reflective Optical Imaging Device for Early Detection of Breast Cancer.Bioengineering (Basel). 2023 Nov 1;10(11):1272. doi: 10.3390/bioengineering10111272. Bioengineering (Basel). 2023. PMID: 38002396 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical